Brenda L. Case

760 total citations
15 papers, 616 citations indexed

About

Brenda L. Case is a scholar working on Organic Chemistry, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Brenda L. Case has authored 15 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 6 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Brenda L. Case's work include Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Synthesis of β-Lactam Compounds (3 papers). Brenda L. Case is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Synthesis of β-Lactam Compounds (3 papers). Brenda L. Case collaborates with scholars based in United States. Brenda L. Case's co-authors include David E. Bergbreiter, Yun‐Shan Liu, John W. Caraway, John J. Parlow, Michael S. South, Rhonda M. Lachance, Thomas Girard, Nancy S. Nicholson, Ronald R. Hiebsch and Justine G. Franchina and has published in prestigious journals such as Macromolecules, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Brenda L. Case

15 papers receiving 590 citations

Peers

Countries citing papers authored by Brenda L. Case

Since Specialization

Citations

This map shows the geographic impact of Brenda L. Case's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda L. Case with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda L. Case more than expected).

Fields of papers citing papers by Brenda L. Case

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brenda L. Case. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda L. Case. The network helps show where Brenda L. Case may publish in the future.

Co-authorship network of co-authors of Brenda L. Case

This figure shows the co-authorship network connecting the top 25 collaborators of Brenda L. Case. A scholar is included among the top collaborators of Brenda L. Case based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda L. Case. Brenda L. Case is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Part II: Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation 2010 ·Bioorganic & Medicinal Chemistry Letters ·John J. Parlow, (unknown), Brenda L. Case, Thomas Girard, (unknown), Peter K. Harris, Ronald R. Hiebsch, Rita M. Huff, Rhonda M. Lachance, Deborah A. Mischke, Stephen R. Rapp, (unknown), Michael D. Ennis	14
2	Biochemical, Cellular, and Anti-Inflammatory Properties of a Potent, Selective, Orally Bioavailable Benzamide Inhibitor of Rho Kinase Activity 2010 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), (unknown), Larry E. Kahn, (unknown), Hideaki Shimada, (unknown), Ben S. Zweifel, Jay M. Wendling, Maria Payne, (unknown), Brenda L. Case, (unknown), Mihir D. Parikh, Olga V. Nemirovskiy, Robert J. Mourey, Jaime L. Masferrer, Thomas P. Misko, Stephen A. Kolodziej	8
3	Discovery of Novel Cyanodihydropyridines as Potent Mineralocorticoid Receptor Antagonists 2010 ·Journal of Medicinal Chemistry ·(unknown), Scott S. Woodard, Kaliappan Iyanar, Brenda L. Case, (unknown), Jessica D. Dietz, Danny J. Garland, Joe Collins, Maria Payne, James R. Blinn, Silvia Pomposiello, Xiao Hu, Marcia I. Heron, H. T. Huang, Len F. Lee	35
4	Piperazinyl Glutamate Pyridines as Potent Orally Bioavailable P2Y₁₂ Antagonists for Inhibition of Platelet Aggregation 2010 ·Journal of Medicinal Chemistry ·John J. Parlow, (unknown), Brenda L. Case, Thomas Girard, (unknown), Peter K. Harris, Ronald R. Hiebsch, Rita M. Huff, Rhonda M. Lachance, Deborah A. Mischke, Stephen R. Rapp, (unknown), Michael D. Ennis	40
5	Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation 2009 ·Bioorganic & Medicinal Chemistry Letters ·John J. Parlow, (unknown), Brenda L. Case, Thomas Girard, (unknown), Ronald R. Hiebsch, Rita M. Huff, Rhonda M. Lachance, Deborah A. Mischke, Stephen R. Rapp, (unknown), Michael D. Ennis	24
6	Piperazinyl-glutamate-pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation 2009 ·Bioorganic & Medicinal Chemistry Letters ·John J. Parlow, (unknown), Brenda L. Case, Thomas Girard, (unknown), Ronald R. Hiebsch, Rita M. Huff, Rhonda M. Lachance, Deborah A. Mischke, Stephen R. Rapp, (unknown), Michael D. Ennis	18
7	Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex 2003 ·Bioorganic & Medicinal Chemistry Letters ·Michael S. South, Brenda L. Case, (unknown), Darin E. Jones, Michael Hayes, Thomas Girard, Rhonda M. Lachance, Nancy S. Nicholson, Michael Clare, Anna M. Stevens, Roderick A. Stegeman, William C. Stallings, Ravi G. Kurumbail, John J. Parlow	32
8	Administration of a small molecule tissue factor/Factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time 2003 ·Thrombosis Research ·James A. Szalony, (unknown), Anita K. Salyers, Susan G. Panzer‐Knodle, (unknown), Rhonda M. Lachance, Brenda L. Case, John J. Parlow, Michael S. South, (unknown), Nancy S. Nicholson	31
9	A method for determining whether hypotension caused by novel compounds in preclinical development results from histamine release 2003 ·Journal of Pharmacological and Toxicological Methods ·(unknown), (unknown), Nancy S. Nicholson, Brenda L. Case, John J. Parlow, Michael S. South, Craig D. Wegner	3
10	Design, Parallel Synthesis, and Crystal Structures of Pyrazinone Antithrombotics as Selective Inhibitors of the Tissue Factor VIIa Complex 2003 ·Journal of Medicinal Chemistry ·John J. Parlow, Brenda L. Case, (unknown), (unknown), Michael J. Hayes, Darin E. Jones, William L. Neumann, (unknown), Rhonda M. Lachance, Thomas Girard, Nancy S. Nicholson, Michael Clare, Roderick A. Stegeman, Anna M. Stevens, William C. Stallings, Ravi G. Kurumbail, Michael S. South	57
11	Multi-Step Polymer-Assisted Solution-Phase (PASP) Library Synthesis of Functionalized Diaminobenzamides 2000 ·Combinatorial Chemistry & High Throughput Screening ·Michael S. South, Brenda L. Case, (unknown), (unknown), Michael Hayes, Darin E. Jones, (unknown), Qingping Zeng, John J. Parlow	5
12	Fluoroacrylate-Bound Fluorous-Phase Soluble Hydrogenation Catalysts 2000 ·Organic Letters ·David E. Bergbreiter, Justine G. Franchina, Brenda L. Case	24
13	High-throughput purification of solution-phase periodinane mediated oxidation reactions utilizing a novel thiosulfate resin 1999 ·Tetrahedron ·John J. Parlow, Brenda L. Case, Michael S. South	36
14	Pd-Catalyzed synthesis of a tethered soluble polymeric phosphine ligand 1998 ·Tetrahedron Letters ·David E. Bergbreiter, Yun‐Shan Liu, (unknown), Brenda L. Case	17
15	Poly(N-isopropylacrylamide) Soluble Polymer Supports in Catalysis and Synthesis 1998 ·Macromolecules ·David E. Bergbreiter, Brenda L. Case, Yun‐Shan Liu, John W. Caraway	272

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact